Australia's most trusted
source of pharma news
Tuesday, 29 April 2025
Posted 18 July 2024 AM
Bayer ANZ is ahead of the curve in the company's global structural transformation and has been named a 'frontrunner team' paving the way for the rest of the organisation.
Earlier this year Bayer announced it would implement a new global operating model called Dynamic Shared Ownership (DSO), designed to reduce hierarchies and eliminate bureaucracy. However, the Bayer ANZ Pharma team proactively pursued an agile transformation early last year.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.